US Stock MarketDetailed Quotes

PHASQ PhaseBio Pharmaceuticals

Watchlist
  • 0.000001
  • 0.0000000.00%
15min DelayClose Sep 16 16:00 ET
49.86Market Cap0.00P/E (TTM)

PhaseBio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PhaseBio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2022/Q2208.000K / 500.000K--
--2022/Q1117.000K / 2.334M--
--2021/Q4158.000K / 1.966M--
--2021/Q3335.000K / 1.066M--
--2021/Q210.338M / 5.020M--
DatePeriodRevenue/EstimateEarnings Call
--2022/Q2208.000K / 500.000K--
--2022/Q1117.000K / 2.334M--
--2021/Q4158.000K / 1.966M--
--2021/Q3335.000K / 1.066M--
--2021/Q210.338M / 5.020M--

Unlock Free Earnings Estimates

PhaseBio Pharmaceuticals Earnings Reports

  • PhaseBio Pharmaceuticals | 10-Q: Q2 2022 Earnings Report

    Aug 12, 2022 08:36 ET

  • PhaseBio Pharmaceuticals | 10-Q: Q1 2022 Earnings Report

    May 16, 2022 06:06 ET

  • PhaseBio Pharmaceuticals | 10-K: FY2021 Annual Report

    Mar 24, 2022 16:14 ET

  • PhaseBio Pharmaceuticals | 10-Q: Q3 2021 Earnings Report

    Nov 10, 2021 16:38 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    +14.85%
    New Fortress Energy
    NFE
    +7.92%
    Cars.com
    CARS
    +2.11%
    Halozyme Therapeutics
    HALO
    +1.31%
    Collegium Pharmaceutical
    COLL
    +0.40%

    Unlock the Full List